2026 NPPES data Hematology & Oncology Physician NPI 1467557694 MD
Verify on CMS →

STEPHEN FIRSHEIN, MD

Hematology & Oncology Physician in HARTFORD, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 272 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.5K
70 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: STEPHEN FIRSHEIN, MD is a Hematology & Oncology Physician ([object Object]) practicing in HARTFORD, Connecticut with a Medicare Part D prescribing footprint of 2K claims across 272 beneficiaries — 20% brand-name prescribing . Industry payments of $1.5K across 70 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: STEPHEN FIRSHEIN, MD filed 2,413 Medicare Part D claims in 2023 across HARTFORD, Connecticut. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

STEPHEN FIRSHEIN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

STEPHEN FIRSHEIN, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 09/13/2006

NPI 1467557694

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

2,413 185% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Connecticut

How Hematology & Oncology Physician compares to other specialties among Connecticut providers

Connecticut providers

Hematology & Oncology Physician share within Connecticut

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Connecticut

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEPHEN FIRSHEIN, MD is a Hematology & Oncology Physician provider practicing in HARTFORD, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1467557694. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

STEPHEN FIRSHEIN, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 85 SEYMOUR ST, HARTFORD, CT, 06106, with a listed phone of (860) 246-6647. NPI 1467557694 was issued on 09/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FIRSHEIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,413 prescription claims written by this provider, covering 272 Medicare beneficiaries and totaling roughly $4.4 million in drug spend, split 20% brand-name and 80% generic by claim count, with an opioid prescribing rate of 1.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

85 SEYMOUR ST
HARTFORD, CT 06106

Provider Details

NPI 1467557694
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 09/13/2006

Hospital and facility affiliations

Facilities where STEPHEN FIRSHEIN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

STARLING PHYSICIANS, PLLC
AVON, CT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEPHEN FIRSHEIN, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.5K

Largest payer

Celgene Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

STEPHEN FIRSHEIN, MD — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 2,413 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,413
Total Claims
$4.4M
Total Drug Cost
272
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,851
Total Day Supply
140,958
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$4.2M
Generic Drug Cost
$220K
Opioid Claims
27 (1.1% rate)
Antibiotic Claims
70

Patient Demographics

Average Patient Age
76.0 years
Avg HCC Risk Score
1.51
Gender Split
44% female / 56% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
134
Hydroxyurea
108
Jakafi
Ruxolitinib Phosphate
69
Prednisone
64
Amlodipine Besylate
63
Levothyroxine Sodium
58
Revlimid
Lenalidomide
56
Rosuvastatin Calcium
56
Metformin Hcl
55
Alprazolam
54

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How STEPHEN FIRSHEIN, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

STEPHEN FIRSHEIN, MD's 2,413 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as FIRSHEIN.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEPHEN FIRSHEIN, MD's specialty?
STEPHEN FIRSHEIN, MD specializes in Hematology & Oncology Physician and practices in HARTFORD, Connecticut. Credentials: MD.
How much does STEPHEN FIRSHEIN, MD prescribe under Medicare Part D?
In 2023, STEPHEN FIRSHEIN, MD wrote 2,413 Medicare Part D claims totaling $4.4M in drug costs for 272 beneficiaries.
Where is STEPHEN FIRSHEIN, MD located?
STEPHEN FIRSHEIN, MD is located at 85 SEYMOUR ST, HARTFORD, CT, 06106. Phone: (860) 246-6647.
What is STEPHEN FIRSHEIN, MD's NPI number?
STEPHEN FIRSHEIN, MD's National Provider Identifier (NPI) is 1467557694, issued on 09/13/2006.
Does STEPHEN FIRSHEIN, MD prescribe more brand-name or generic drugs?
STEPHEN FIRSHEIN, MD's prescribing is 20% brand-name and 80% generic drugs by claim count, with $4.2M in brand drug costs.
Does STEPHEN FIRSHEIN, MD prescribe opioids?
Yes, STEPHEN FIRSHEIN, MD had 27 opioid claims in 2023 with an opioid prescribing rate of 1.1%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does STEPHEN FIRSHEIN, MD prescribe most often?
Based on 2023 Medicare Part D data, STEPHEN FIRSHEIN, MD's most frequently prescribed drugs include Atorvastatin Calcium, Hydroxyurea, Jakafi. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEPHEN FIRSHEIN, MD accept Medicare?
STEPHEN FIRSHEIN, MD appears in CMS Medicare data with 2,413 Part D claims and 272 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEPHEN FIRSHEIN, MD's credentials?
STEPHEN FIRSHEIN, MD's NPI is 1467557694 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology